Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report.
Caroline W EspinolaYuelee KhooRoohie ParmarIlya DemchenkoBenicio N FreyRoumen V MilevArun V RavindranSagar V ParikhKeith HoSusan RotzingerWendy LouRaymond W LamSidney H KennedyVenkat BhatPublished in: Journal of psychopharmacology (Oxford, England) (2022)
For both sexes, sexual satisfaction improves with response to escitalopram. For females, the response does not correspond to improvements in SF frequency. For males, SF frequency, particularly that of orgasm, declines regardless of response/nonresponse.ClinicalTrials.gov identifier: NCT01655706.